Clinical Trials Browser

Phase NA × OTHER × Endocrine × Clear all

NCT06629220 2026-04-14

Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior

Phase NA Completed

Suicide Prevention, Multiple Endocrine Neoplasia Type 1, Suicidal Ideation

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Phase NA Not yet recruiting

DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT06141369 2026-04-09

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Phase NA Recruiting

Adenoma, Islet Cell, Adrenocortical Carcinoma, Carcinoma, Medullary

NCT07247526 2026-04-09

Effect of Foot Bath on Anxiety and Physiological Parameters

Phase NA Completed

Anxiety Disorders, Pituitary Neoplasms

NCT06826170 2026-03-30

HYPOADENO

Phase NA Completed

Pituitary Neoplasms

NCT04074642 2026-03-24

FIRST

Phase NA Completed

Pituitary Neoplasms

NCT04804371 2026-03-23

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Phase NA Active not recruiting

Neuroendocrine Tumors

NCT07470580 2026-03-13

ADERADHTA2

Phase NA Not yet recruiting

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT04175678 2026-03-10

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Phase NA Active not recruiting

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

NCT07458906 2026-03-09

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

Phase NA Recruiting

Carcinoma, Neuroendocrine

NCT05604963 2026-03-05

HoT

Phase NA Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT03416686 2026-02-25

METATHYRAF

Phase NA Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT07068542 2026-02-24

TROPION

Phase NA Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Phase NA Recruiting

EndocrineGastrointestinalNET

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT04278118 2026-02-17

HiPPI

Phase NA Recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT07412782 2026-02-17

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

Phase NA Recruiting

Bone Diseases, Metabolic, Cushing Syndrome, Dwarfism, Pituitary, Neoplasms, Obesity, Osteogenesis Imperfecta, Osteoporosis, Malnutrition, Overweight

NCT01022515 2026-02-06

PHEO

Phase NA Completed

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

Phase NA Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT05599139 2026-02-06

IULID

Phase NA Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT04104529 2026-02-05

BCB RIV

Phase NA Recruiting

EndocrineGenitourinaryHead & NeckNET

Prostatic Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors

NCT06235814 2026-02-05

MAPS

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06297473 2026-01-29

PITCARE

Phase NA Enrolling by invitation

Non-Functional Pituitary Adenoma

NCT07376837 2026-01-29

PTC-RFA

Phase NA Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT05014698 2026-01-28

IDENTHY-K

Phase NA Terminated

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06954909 2026-01-28

The Impact of Self-assessment on Hydration

Phase NA Enrolling by invitation

Multiple Endocrine Neoplasia Type 1

NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

Phase NA Not yet recruiting

EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT02826928 2026-01-21

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors

Phase NA Completed

Carcinoid Tumor

NCT05735912 2026-01-13

ERASIN-RCT

Phase NA Active not recruiting

Insulinoma

NCT06584123 2026-01-06

FET-pit-PET

Phase NA Recruiting

Pituitary Neoplasms

NCT07316101 2026-01-05

Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

Phase NA Not yet recruiting

Craniopharyngioma, Pituitary Neoplasms

NCT06788886 2025-12-30

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Phase NA Recruiting

CNSEndocrineGenitourinaryNET

Brain Neoplasms, Multiple Sclerosis, Prostatic Neoplasms, Neuroendocrine Tumors

NCT04813042 2025-12-24

WOD

Phase NA Active not recruiting

Psychological Well-Being, Multiple Endocrine Neoplasia Type 1

NCT07302672 2025-12-24

Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

Phase NA Recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Anxiety Disorders

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Phase NA Completed

Neuroblastoma, Pheochromocytoma

NCT07288931 2025-12-17

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

Phase NA Recruiting

Paraganglioma, Pheochromocytoma

NCT07274657 2025-12-10

SMILE

Phase NA Not yet recruiting

EndocrineGastrointestinalNETOther solid neoplasm

Pancreas Adenocarcinoma (MSI-H)

NCT06735560 2025-12-08

ELEGANCE

Phase NA Recruiting

EndocrineGastrointestinalNET

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

NCT02743741 2025-12-03

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

Phase NA Active not recruiting

Neuroendocrine Tumors

NCT06623578 2025-12-03

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Phase NA Recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

NCT03217097 2025-11-21

MGMT-NET

Phase NA Completed

Neuroendocrine Tumors

NCT06876532 2025-11-18

LUTIBI

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

NCT07216157 2025-10-14

NoSeal

Phase NA Recruiting

Cerebrospinal Fluid Otorrhea, Pituitary Neoplasms

NCT06256705 2025-09-22

OPERANDI-NET

Phase NA Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT06831461 2025-09-16

PRIDE

Phase NA Recruiting

Brain Neoplasms, Meningioma, Pituitary Neoplasms

NCT07141147 2025-09-03

A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.

Phase NA Not yet recruiting

Adrenocortical Carcinoma

NCT06908629 2025-08-26

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Phase NA Recruiting

EndocrineGastrointestinalNETPlasma cell

Gastrointestinal Neoplasms, Multiple Myeloma, Neoplasms, Neuroendocrine Tumors

NCT04186260 2025-08-24

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

Phase NA Completed

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Overweight, Non-alcoholic Fatty Liver Disease

NCT06648967 2025-08-21

Impact of Different Carbohydrate Feedings on a Hydrogen Breath Curve and Self-reported Gastrointestinal Complaints

Phase NA Active not recruiting

Malabsorption Syndromes, Multiple Endocrine Neoplasia Type 1

NCT01471639 2025-08-15

Sprix

Phase NA Completed

37 enrolled 7 charts

Emergencies, Multiple Endocrine Neoplasia Type 1

NCT01879657 2025-08-06

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Phase NA Completed

Carcinoma, Neuroendocrine